Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 28 of 28 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/22/20
End: 01/01/26
Due: 01/01/27
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 04/30/25
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia | NCT04534127 | Alpha Tau Medical LTD. | user2@example.com | None | 2020-12-22 | 2026-01-01 | 2027-01-01 | - | - | 2025-07-14 |
| A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma | NCT06910306 | Alpha Tau Medical LTD. | user2@example.com | None | 2025-05-01 | 2026-12-01 | 2027-12-01 | - | - | 2025-07-14 |
| Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer | NCT06698458 | Alpha Tau Medical LTD. | user2@example.com | None | 2025-04-30 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |